mainphoto_aboutus

Our Vision

Our vision is to work collaboratively with sponsors to provide services globally to develop new products.

Our Mission

Our mission is to provide superior new product development services to life science companies by applying our expertise, experience and innovation in the global market.

Our Values

  • To apply the highest standards of excellence to the development of pharmaceutical and medical products.
  • To provide clients with quality services while achieving cost savings through our experience and use of innovative technology.
  • To display the highest ethical and moral standards in all that we do.
  • To seek to understand and respect the local people, culture and regulations wherever we operate around the world, and to conduct ourselves as professionals representing our clients.
  • To work with partners and vendors with honesty and dignity to achieve results.
  • To work with clients during challenging times to find solutions for difficult problems.

Company News

CTI Expands Re-monitoring Program to South America

Our Re-monitoring Program continues to be important to the overall objectives of the company.   With a recent contract in Brazil, Argentina and Mexico, CRAs followed a specific re-monitoring plan at high enrolling sites.  The findings give the sponsor some assurance of the quality of the overall monitoring in a trial.

Posted January 27, 2011

CTI Launches Voice Recognition Software

To facilitate the documentation of site visits, field CRAs were introduced to voice recognition software. The use of this software allows the CRA to document findings after reviewing each page of the case report form. This documentation serves the CRA in report completion, the study coordinator with data corrections and the clinical trial manager with any data collection issues needing special attention.

Posted January 1, 2011

CTI Introduced the STAT Visit Report

In an effort to expedite the flow of important information following routine site visits, a short version of the site visit report was introduced. The STAT visit report focuses on key information that is emailed to the sponsor within 24 hours of the site visit. This report can be processed securely with an encrypted email and electronic signature. The traditional Site Visit Report would still be provided at a later date.

Posted October 1, 2010

CTI Adds New Advisors to the Team

To move forward with the long-term plan to conduct trials worldwide, CTI welcomes new advisors to the group.

Posted December 10, 2009

CTI Executes Its First Auditing and Re-monitoring Agreement

Our first agreement was signed with a Japanese subsidiary in the United States to audit and re-monitor a pivotal clinical trial. This new agreement allowed CTI to validate the new program launched just a month ago.

Posted September 2, 2009

CTI Initiates a New Program for Auditing and Re-monitoring Clinical Data

CTI initiated a new program to focus on auditing and re-monitoring clinical data for pivotal studies. The focus will be on auditing clinical data, along with other quality assurance activities evolving from the program.

Posted August 5, 2009

CTI Launches New Website

As with any new company, a website is an essential tool to reach potential clients about CTI’s mission, vision, services, and experience. The logo “Meeting the Challenges of Clinical Trials” was also an important step in defining the company’s focus.

Posted July 12, 2009

Clinical Trials International Incorporates

Clinical Trials International (CTI) incorporated its business in the state of Nevada. Incorporating has several advantages over other business entities but more importantly the founders accomplished some of the major hurdles required in establishing the company.

Posted June 22, 2009